NIVABUPA vs SGFIN: Stock Comparison

NIVA BUPA HEALTH INS CO L vs SG FINSERVEUpdated 2 Sept 26, 4:08 PM ISTNSE & company filings

NIVA BUPA HEALTH INS CO L is the larger company by market capitalisation. SG FINSERVE shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

NIVABUPA leads 0; SGFIN leads 8 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

NIVABUPASGFIN

Valuation lens

What price are you paying?

Market CapContext only
₹14,923 Cr
₹4,470 Cr
P/E RatioSGFIN has the lower reading
116.18x
26.66x
P/B RatioSGFIN has the lower reading
4x
3.04x
EPSSGFIN has the higher reading
₹1.87
₹8.15
Book ValueContext only
₹23.73
₹221.6
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NIVABUPA is the larger company
₹14,923 Cr vs ₹4,470 Cr
P/E Ratio
SGFIN has a lower P/E
26.66x vs 116.18x
P/B Ratio
SGFIN has a lower P/B
3.04x vs 4x
EPS
SGFIN has higher earnings per share
₹8.15 vs ₹1.87
Revenue Growth (TTM YoY)
SGFIN has faster revenue growth
97% vs 26.8%
EPS Growth (TTM YoY)
SGFIN has faster EPS growth
106% vs 90.2%
ROE
SGFIN has a higher ROE
8.74% vs 0%
ROCE
SGFIN has a higher ROCE
5.81% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNIVABUPASGFIN
SectorFinancial ServicesFinancial Services
IndustryGeneral InsuranceNon Banking Financial Company (NBFC)

Price

MetricNIVABUPASGFIN
Live Price₹80.73₹674.6
Day Change-1.91%-1.13%
Volume3.66 L1.17 L
52-Week High₹91.4₹727.45
52-Week Low₹67.5₹323
Distance from 52W High-11.67%-7.27%

Valuation

MetricNIVABUPASGFIN
Market Cap₹14,923 Cr₹4,470 Cr
P/E Ratio116.18x26.66x
P/B Ratio4x3.04x
EPS₹1.87₹8.15
Book Value₹23.73₹221.6
Dividend Yield0%0%

Growth

MetricNIVABUPASGFIN
Revenue Growth (TTM YoY)26.8%97%
EPS Growth (TTM YoY)90.2%106%
Qtr Sales Growth29.14%
Qtr Profit Growth26.99%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricNIVABUPASGFIN
ROE0%8.74%
ROCE0%5.81%
Net Margin4.34%39.27%
Operating Margin91.62%
Debt to Equity0.07x1.82x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNIVABUPASGFIN
Promoter Holding0%56.95% 4.03 pp
FII Holding12.09% 1.49 pp0.54% 0.28 pp
DII Holding16.17% 0.32 pp2.17% 1.11 pp
Public Holding16.44% 1.11 pp40.34% 3.2 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NIVA BUPA HEALTH INS CO L and SG FINSERVE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.